Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Chemotherapy in Second-line Metastatic Colorectal Cancer
NCT00889343Phase 2Terminated
- Sponsor
- AIO-Studien
- Start
- Mar 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in colorectal cancer (CRC), sponsored by AIO-Studien. Started Mar 2009; status: terminated.
02
Drugs
sorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00889343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889343.